The median level of CPT1A in serum from breast cancer patients after surgery was 32.16 ± 22.54 ng/mL, which was significantly lower than its level before surgery (Fig. 6a, b, left; 45.61 ± 45.89 ng/mL, p < 0.0001). This evidence concerns the gene CPT1A and breast carcinoma.